Changes in bone mineral density after allogenic stem cell transplantation.
Sign Up to like & getrecommendations! Published in 2022 at "Joint bone spine"
DOI: 10.1016/j.jbspin.2022.105373
Abstract: OBJECTIVE Osteoporosis is a complication after allogenic stem cell transplantation (alloSCT). The purpose of this study was to assess changes in bone mineral density (BMD) 6 months and 3 years after alloSCT, as well as… read more here.
Keywords: cell transplantation; allogenic stem; stem; stem cell ... See more keywords
Allogenic stem cell transplant in patients over the age of 70, including octogenarians, with hematologic malignancies: A single institution experience.
Sign Up to like & getrecommendations! Published in 2017 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2017.35.15_suppl.e18538
Abstract: e18538Background: Patient age is an important factor when considering allogenic stem cell transplant (aSCT) as a treatment modality for hematologic malignancies. Previous series exploring older age... read more here.
Keywords: age; allogenic stem; hematologic malignancies; stem cell ... See more keywords
Sarcopenia Screening Allows Identifying High-Risk Patients for Allogenic Stem Cell Transplantation
Sign Up to like & getrecommendations! Published in 2021 at "Cancers"
DOI: 10.3390/cancers13081771
Abstract: Simple Summary Allogenic stem cell transplantation is a treatment option for various hematological diseases. Due to the intensity of the therapy regimes used, there is a substantial therapy associated mortality and morbidity. Therefore, it is… read more here.
Keywords: sarcopenia; risk; allogenic stem; mortality ... See more keywords